Abstract
Background: Syndemics happened while two or more coinfections have dangerous interaction and lead to a harmful outcome than for either single infection. In Indonesia, during COVID-19 pandemic, it has deal with a doble burden presume to neglected tropical disese (NTD) control. Parasitic disease as a part of NTD must be a concern in Indonesia along pandemc. There are still few articles that review the biomedical aspects of co-infection COVID-19 with parasitic diseases in Indonesia, whereas an understanding of biomedical aspects can encourage knowledge about pathogenesis which will make an earlier diagnosis.
Results: This review summarize how parasites may serve as protective agents or risk factors in pandemic and, vice versa, how the COVID-19 may disturb the prevention and misdiagnosis of parasitic disease in Indonesia. Co-infection COVID-19 with malaria increass the burden of severe clinical manifestations and poor prognosis due to exaggerated proinflammatory response. Coinfection triggers TNF and IL-6 to activate coagulation cascade leading to micro-thrombosis and coagulopathy. Besides, helminthiasis causes vary configuration of immune-modulation, thereby lowering susceptibility to other infections and tolerating COVID-19 better. They modify Th2 respons to limit pro-inflammatory cytokines, such as IL-6 which is observed in severe cases of COVID-19. T-cell hypoactivation in SARS-CoV-2 and W.bancrofti will cause relatively mild manifestation of COVID-19.
Conclusions: In parasite infection, the IL-4 may elevate and induce shadow memory CD8+ T-cell (TVM cell) for CD8 response rapidly agains virus. It control human IL-4 or IL-10 that leads to the maturation of Th2 cells and down-regulation of the inflamation respons of IFN-g, IL-17 and TNF-a. These mechanisms allow us to blockade the cytokines storms observed in COVID-19 cases.
Publisher
Universitas Nahdlatul Ulama Surabaya
Reference51 articles.
1. Ajibola O, Gulumbe BH, Eze AA, Obishakin E. Tools for detection of schistosomiasis in resource limited settings. Med Sci (Basel) 6: 39 (2018)
2. Centres for Disease Control and Prevention. Parasite Schistosomiasis. https://www.cdc.gov/parasites/schistosomiasis/disease Accessed September 7th, 2022
3. Cheepsattayakorn A, Cheepsattayakorn R. Parasitic pneumonia and lung involvement. Biomed Res Int. (2015) 874021
4. Cimino RO, Fleitas P, Fernandez M, Echazu A, Juarez M, Floridia-Yapur N, Cajal P, et al. Seroprevalence of the Strongyloides stercoralis infection in human from Yungas Rainforest and Gran Chaco Region from Argentina and Bolivia. Pathogens (2020) 9, 394
5. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet 383: 2253-64 (2015)